Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.3404
-0.0126 (-3.57%)
At close: Jul 2, 2026, 4:00 PM EDT
0.3300
-0.0104 (-3.06%)
After-hours: Jul 2, 2026, 5:31 PM EDT
Werewolf Therapeutics Employees
Werewolf Therapeutics had 14 employees as of March 31, 2026. The number of employees decreased by 25 or -64.10% since the number was last reported on December 31, 2025.
Employees
14
Change
-25
Growth
-64.10%
Revenue / Employee
n/a
Profits / Employee
-$4,018,929
Market Cap
16.54M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 14 | -25 | -64.10% |
| Dec 31, 2025 | 39 | -7 | -15.22% |
| Dec 31, 2024 | 46 | -1 | -2.13% |
| Dec 31, 2023 | 47 | 1 | 2.17% |
| Dec 31, 2022 | 46 | 7 | 17.95% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Quince Therapeutics | 38 |
| Passage Bio | 24 |
| Citius Pharmaceuticals | 23 |
| CalciMedica | 16 |
| BioVie | 13 |
| Tempest Therapeutics | 5 |
| GT Biopharma | 1 |
HOWL News
- 2 months ago - Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 2 months ago - Werewolf Therapeutics Quarterly report: Q1 2026 - Filings
- 2 months ago - Werewolf Therapeutics Earnings release: Q1 2026 - Filings
- 3 months ago - Werewolf Therapeutics hires Piper Sandler to assist in strategic evaluation - TheFly
- 3 months ago - Werewolf Therapeutics reports Q4 EPS (20c), consensus (35c) - TheFly
- 3 months ago - Werewolf Therapeutics to explore range of strategic alternatives - TheFly
- 3 months ago - Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 3 months ago - Werewolf Therapeutics Annual report: Q4 2025 - Filings